-
India Globalization Capital (IGC) Tops Q2 EPS by 1c
-
IGC Pharma (IGC) Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment
-
India Globalization Capital (IGC) Tops Q1 EPS by 1c
-
IGC Pharma (IGC): Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
-
IGC Pharma's (IGC) TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque

